Logo BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
BioLife Solutions, Inc. · Health Care · ref. ETF XLV · 53 calls · price $37.2
🔔Price alertsCreate an alert →
What the company does: BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry.

📈 BioLife Solutions, Inc. (BLFS) stock price

$37.2+49.3% over range
Aug 28, 25low $18.15 · high $37.22Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 6 analysts
📊 JPI status : BioLife Solutions, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 BLFS price target & analyst consensusprice $37.20

The price target · all analysts combined (5 targets)
Highest target · 5 firms of 5$31-16.7%
Median target · of 5 targets$31-16.7%
Lowest target · 5 firms of 5$31-16.7%
Current price$37.2
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Below 5100% $31
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Lake Street65% of its targets hit on this sector (26 calls tested). It aims for $31 (-17 %), call made on July 23, 2026, maturing on July 23, 2027 (36 d ago).

The 3 reliable analysts $31-17 %
The 2 other firms $31-17 %
How to read it: the 3 reliable firms are not filtered by optimism — 0 aim above the price, 3 below, hence their $31 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold6100%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about BioLife Solutions, Inc.? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

🏛️ Which US Congress members hold BioLife Solutions, Inc. (BLFS)?

1 Congress member has disclosed BLFS buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on BLFS

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
B. Riley Securities  100% +177.8% 4
Lake Street 100% +132.8% 2
Maxim Group 100% +95.1% 2
HC Wainwright & Co.  75% +68.0% 8
TD Cowen  67% +37.2% 3
Oppenheimer  67% +34.4% 3
Stephens & Co.  67% +20.9% 3
Benchmark  50% +27.1% 4
Craig-Hallum  50% +26.2% 4
Keybanc  40% +2.5% 5
See the other 1 firms
Northland Capital Markets  33% -3.6% 3

📊 What $1,000 invested in BioLife Solutions, Inc. would be worth › open the full page

In short — $1,000 invested in BioLife Solutions, Inc. 10 years ago would be worth $13,203 today, i.e. +29%/yr on average. Best year: 2017 (+273%), worst: 2022 (-51%). Price performance, excluding dividends.

If I'd invested $1,000 in BioLife Solutions, Inc.

InvestmentWorth todayGain
1 years ago$1,104+10%
3 years ago$1,574+57%
5 years ago$718-28%
→ See BioLife Solutions, Inc.'s full return history + gain calculator

Return by year (BioLife Solutions, Inc.)

YearReturn$1,000 invested at year start
2026 (YTD)+18%$1,185 (+18%)
2025-7%$1,104 (+10%)
2024+60%$1,763 (+76%)
→ See BioLife Solutions, Inc.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on BioLife Solutions, Inc.

Loading news…

📋 All analyst calls on BLFS

Benchmark 
Aug 10, 26
■ Hold neutral · not a buy
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Aug 10, 27
Stephens & Co. 
Jul 27, 26
■ Equal-Weight neutral · not a buy · 🎯$31
Price at call : $31.98 — gap to target -3%
Today : $37.2 — gap to target -17%
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Jul 27, 27
Jefferies 
Jul 23, 26
■ Hold neutral · not a buy · 🎯$31
Price at call : $29.98 — gap to target +3%
Today : $37.2 — gap to target -17%
🎯 on BLFS : 100% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Jul 23, 27
TD Cowen 
Jul 23, 26
■ Hold neutral · not a buy · 🎯$31
Price at call : $29.98 — gap to target +3%
Today : $37.2 — gap to target -17%
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Jul 23, 27
Lake Street
Jul 22, 26
■ Hold neutral · not a buy · 🎯$31
Price at call : $30.77 — gap to target +1%
Today : $37.2 — gap to target -17%
🎯 on BLFS : 100% (2 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
in progress (365j)
matures : Jul 22, 27
■ Neutral neutral · not a buy · 🎯$31
Price at call : $31.15 — gap to target -0%
Today : $37.2 — gap to target -17%
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Jul 22, 27
▲ Buy · 🎯$32
Price at call : $25.12 — upside +27%
Today : $37.2 — upside -14%
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Dec 29, 26
▲ Buy · 🎯$32
Price at call : $26.35 — upside +21%
Today : $37.2 — upside -14%
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Nov 24, 26
See the other 45 calls, newest to oldest
▲ Buy · 🎯$32
Price at call : $22.68 — upside +41%
Today : $37.2 — upside -14%
Expected +41% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+52.7%
stock +53% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$30
Price at call : $23.09 — upside +30%
Today : $37.2 — upside -19%
Expected +30% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-8.3%
stock -8% · XLV +11%
matured May 13, 26
▲ Buy · 🎯$30
Price at call : $26.8 — upside +12%
Today : $37.2 — upside -19%
Expected +12% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-25.9%
stock -26% · XLV +2%
matured Mar 6, 26
▲ Outperform · 🎯$31
Price at call : $27.69 — upside +12%
Today : $37.2 — upside -17%
Expected +12% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 33% (3 calls matureds) · 📊 on Health : 15.4% · -20.8% (13 calls)
-9.9%
stock -10% · XLV +13%
matured Jan 8, 26
Benchmark 
Dec 19, 24
▲ Buy · 🎯$30
Price at call : $26.11 — upside +15%
Today : $37.2 — upside -19%
Expected +15% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-4.0%
stock -4% · XLV +14%
matured Dec 19, 25
Keybanc 
Dec 13, 24
▲ Overweight · 🎯$33
Price at call : $27.37 — upside +21%
Today : $37.2 — upside -11%
Expected +21% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 40% (5 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-9.9%
stock -10% · XLV +12%
matured Dec 13, 25
▲ Buy · 🎯$27
Price at call : $20.47 — upside +32%
Today : $37.2 — upside -27%
Expected +32% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+17.4%
stock +17% · XLV +8%
matured Nov 18, 25
TD Cowen 
Nov 13, 24
▲ Buy · 🎯$31
Price at call : $21.65 — upside +43%
Today : $37.2 — upside -17%
Expected +43% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
+11.2%
stock +11% · XLV +5%
matured Nov 13, 25
Craig-Hallum 
Nov 13, 24
▲ Buy · 🎯$32
Price at call : $21.65 — upside +48%
Today : $37.2 — upside -14%
Expected +48% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
+11.2%
stock +11% · XLV +5%
matured Nov 13, 25
▲ Buy · 🎯$29
Price at call : $25.04 — upside +16%
Today : $37.2 — upside -22%
Expected +16% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+1.9%
stock +2% · XLV -10%
matured Sep 30, 25
Craig-Hallum 
Aug 12, 24
▲ Buy · 🎯$30
Price at call : $26.52 — upside +13%
Today : $37.2 — upside -19%
Expected +13% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
-3.2%
stock -3% · XLV -12%
matured Aug 12, 25
▲ Outperform · 🎯$28
Price at call : $25.8 — upside +9%
Today : $37.2 — upside -25%
Expected +9% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 33% (3 calls matureds) · 📊 on Health : 15.4% · -20.8% (13 calls)
-13.3%
stock -13% · XLV -13%
matured Aug 9, 25
TD Cowen 
Jul 17, 24
▲ Buy · 🎯$26
Price at call : $21.45 — upside +21%
Today : $37.2 — upside -30%
Expected +21% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
-2.9%
stock -3% · XLV -10%
matured Jul 17, 25
Benchmark 
May 13, 24
▲ Buy · 🎯$25
Price at call : $20.66 — upside +21%
Today : $37.2 — upside -33%
Expected +21% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+11.8%
stock +12% · XLV -8%
matured May 13, 25
Jefferies 
Apr 4, 24
▲ Buy · 🎯$22
Price at call : $17.51 — upside +26%
Today : $37.2 — upside -41%
Expected +26% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
+19.3%
stock +19% · XLV -5%
matured Apr 4, 25
Craig-Hallum 
Aug 10, 23
▲ Buy · 🎯$23
Price at call : $12.14 — upside +89%
Today : $37.2 — upside -38%
Expected +89% · Actual +113% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
+112.5%
stock +113% · XLV +10%
matured Aug 9, 24
TD Cowen 
Aug 9, 23
▲ Outperform · 🎯$25
Price at call : $12.42 — upside +101%
Today : $37.2 — upside -33%
Expected +101% · Actual +103% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
+103.3%
stock +103% · XLV +11%
matured Aug 8, 24
Lake Street
Aug 9, 23
▲ Buy · 🎯$25
Price at call : $12.42 — upside +101%
Today : $37.2 — upside -33%
Expected +101% · Actual +103% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (2 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
+103.3%
stock +103% · XLV +11%
matured Aug 8, 24
Stephens & Co. 
Jul 17, 23
▲ Overweight · 🎯$29
Price at call : $20.35 — upside +43%
Today : $37.2 — upside -22%
Expected +43% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+10.6%
stock +11% · XLV +14%
matured Jul 16, 24
Craig-Hallum 
Jul 11, 23
▲ Buy · 🎯$29
Price at call : $22.96 — upside +26%
Today : $37.2 — upside -22%
Expected +26% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
-15.9%
stock -16% · XLV +13%
matured Jul 10, 24
Stephens & Co. 
Mar 17, 23
▲ Overweight · 🎯$27
Price at call : $21.52 — upside +25%
Today : $37.2 — upside -27%
Expected +25% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-21.0%
stock -21% · XLV +15%
matured Mar 16, 24
Oppenheimer 
Mar 6, 23
▲ Outperform · 🎯$28
Price at call : $22.76 — upside +23%
Today : $37.2 — upside -25%
Expected +23% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-25.2%
stock -25% · XLV +12%
matured Mar 5, 24
Stephens & Co. 
May 10, 22
▲ Overweight · 🎯$40
Price at call : $10.54 — upside +280%
Today : $37.2 — upside +8%
Expected +280% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+73.2%
stock +73% · XLV +5%
matured May 10, 23
Keybanc 
May 10, 22
▲ Overweight · 🎯$30
Price at call : $11.75 — upside +155%
Today : $37.2 — upside -19%
Expected +155% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 40% (5 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+58.4%
stock +58% · XLV +5%
matured May 10, 23
Oppenheimer 
Apr 25, 22
▲ Outperform · 🎯$28
Price at call : $13.79 — upside +103%
Today : $37.2 — upside -25%
Expected +103% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+31.5%
stock +32% · XLV -1%
matured Apr 25, 23
Keybanc 
Aug 13, 21
▲ Overweight · 🎯$60
Price at call : $45.32 — upside +32%
Today : $37.2 — upside +61%
Expected +32% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 40% (5 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-42.6%
stock -43% · XLV +0%
matured Aug 13, 22
Benchmark 
May 14, 21
■ Hold neutral · not a buy
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : May 14, 22
Benchmark 
Mar 23, 21
▲ Buy · 🎯$54
Price at call : $41.98 — upside +29%
Today : $37.2 — upside +45%
Expected +29% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-47.2%
stock -47% · XLV +17%
matured Mar 23, 22
Keybanc 
Mar 23, 21
▲ Overweight · 🎯$50
Price at call : $41.98 — upside +19%
Today : $37.2 — upside +34%
Expected +19% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 40% (5 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-47.2%
stock -47% · XLV +17%
matured Mar 23, 22
Keybanc 
Nov 10, 20
▲ Overweight · 🎯$40
Price at call : $32.25 — upside +24%
Today : $37.2 — upside +8%
Expected +24% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 40% (5 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+53.8%
stock +54% · XLV +20%
matured Nov 10, 21
Oppenheimer 
Sep 22, 20
■ Perform neutral · not a buy
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Sep 22, 21
Cowen & Co.
Sep 18, 20
▲ Outperform · 🎯$33
Price at call : $27.21 — upside +21%
Today : $37.2 — upside -11%
Expected +21% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (1 call matured) · 📊 unranked overall
+73.5%
stock +74% · XLV +24%
matured Sep 18, 21
Benchmark 
Aug 11, 20
■ Hold neutral · not a buy
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Aug 11, 21
▲ Buy · 🎯$22
Price at call : $11.47 — upside +92%
Today : $37.2 — upside -41%
Expected +92% · Actual +157% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (3 calls matureds) · 📊 on Health : 48.6% · +36.7% (35 calls)
+157.3%
stock +157% · XLV +26%
matured May 4, 21
▲ Buy · 🎯$17
Price at call : $9.21 — upside +85%
Today : $37.2 — upside -54%
Expected +85% · Actual +323% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+323.0%
stock +323% · XLV +42%
matured Mar 23, 21
▲ Buy · 🎯$24
Price at call : $8.64 — upside +178%
Today : $37.2 — upside -35%
Expected +178% · Actual +339% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (3 calls matureds) · 📊 on Health : 48.6% · +36.7% (35 calls)
+339.5%
stock +339% · XLV +35%
matured Mar 12, 21
Lake Street
Feb 24, 20
▲ Buy · 🎯$25
Price at call : $15.21 — upside +64%
Today : $37.2 — upside -33%
Expected +64% · Actual +162% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (2 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
+162.3%
stock +162% · XLV +18%
matured Feb 23, 21
Benchmark 
Feb 19, 20
▲ Buy · 🎯$24
Price at call : $16.32 — upside +47%
Today : $37.2 — upside -35%
Expected +47% · Actual +148% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 50% (4 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+147.9%
stock +148% · XLV +11%
matured Feb 18, 21
▲ Buy · 🎯$27
Price at call : $13.87 — upside +95%
Today : $37.2 — upside -27%
Expected +95% · Actual +198% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (3 calls matureds) · 📊 on Health : 48.6% · +36.7% (35 calls)
+198.1%
stock +198% · XLV +11%
matured Feb 5, 21
▲ Buy · 🎯$26
Price at call : $15.57 — upside +67%
Today : $37.2 — upside -30%
Expected +67% · Actual +169% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+169.4%
stock +169% · XLV +10%
matured Dec 15, 20
Oppenheimer 
Nov 21, 19
▲ Outperform · 🎯$22
Price at call : $16.48 — upside +33%
Today : $37.2 — upside -41%
Expected +33% · Actual +97% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 67% (3 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+96.7%
stock +97% · XLV +11%
matured Nov 20, 20
▲ Outperform · 🎯$22
Price at call : $19.93 — upside +10%
Today : $37.2 — upside -41%
Expected +10% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 33% (3 calls matureds) · 📊 on Health : 15.4% · -20.8% (13 calls)
+12.4%
stock +12% · XLV +18%
matured Sep 3, 20
▲ Buy · 🎯$23
Price at call : $18.82 — upside +22%
Today : $37.2 — upside -38%
Expected +22% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on BLFS : 75% (8 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+13.9%
stock +14% · XLV +16%
matured Jul 21, 20
Maxim Group
May 11, 18
▲ Buy · 🎯$12
Price at call : $8.62 — upside +39%
Today : $37.2 — upside -68%
Expected +39% · Actual +94% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (2 calls matureds) · 📊 on Health : 40% · +10.1% (5 calls)
+94.1%
stock +94% · XLV +4%
matured May 11, 19
Maxim Group
Nov 10, 17
▲ Buy · 🎯$8
Price at call : $5.91 — upside +35%
Today : $37.2 — upside -78%
Expected +35% · Actual +96% · Reason (≥ +15%) : ✓ Yes
🎯 on BLFS : 100% (2 calls matureds) · 📊 on Health : 40% · +10.1% (5 calls)
+96.1%
stock +96% · XLV +13%
matured Nov 10, 18

Frequently asked questions

Should I buy BioLife Solutions, Inc. stock?

This isn't buy advice. For BioLife Solutions, Inc., the analyst consensus is "Hold", with an average price target of $31.00 (-17% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on BioLife Solutions, Inc.). We show the numbers — you decide.

Is it too late to buy BioLife Solutions, Inc.? How high can it go?

The most bullish analyst target on BioLife Solutions, Inc. is $31.00 (-17% above today's price); the average is $31.00. That's the upside they see. Check how reliable those analysts have actually been on BioLife Solutions, Inc. on our site before trusting it.

Is BioLife Solutions, Inc. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on BioLife Solutions, Inc., the best hitting 100% over 4 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in BioLife Solutions, Inc.? The case for and against

The arguments for and against, one by one, from the numbers: why invest in BLFS (and why hesitate).

What has BioLife Solutions, Inc.'s past performance been?

Historical returns and a "how much if I had invested" calculator: BLFS performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)